PAX.ST
Paxman AB (publ) [PAX.ST] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
PAX.ST Stock Summary
Top 10 Correlated Stocks
PAX.ST
In the News
PAX.ST Financial details
Company Rating
-
Market Cap
714.87M
Income
8.33M
Revenue
210.12M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
91
Optionable
No
Shortable
Yes
Earnings
23 May 2024
P/E
1197.32
Forward P/E
-
PEG
-65.75
P/S
3.63
P/B
5.83
P/C
-
P/FCF
92.21
Quick Ratio
0.46
Current Ratio
1.77
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0.44
EPS next Y
-
EPS next Q
-
EPS this Y
-181.48%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
20.95%
Revenue last 5Y
19.76%
Revenue Q/Q
-9.22%
EPS Q/Q
-122.21%
-
-
-
-
SMA20
-2.79%
SMA50
-11.6%
SMA100
-16.22%
Inst Own
-
Inst Trans
-
ROA
-
ROE
1%
ROC
0.13%
Gross Margin
67%
Oper. Margin
8%
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
22.0-39.7
52W High
+64.1%
52W Low
+190.91%
RSI
41.04
Rel Volume
2.74
Avg Volume
10.47K
Volume
28.67K
Perf Week
-2.74%
Perf Month
-11.11%
Perf Quarter
-11.36%
Perf Half Y
-18.78%
-
-
-
-
Beta
0.71
-
-
Volatility
1.7%, 2.33%
Prev Close
0%
Price
64
Change
-1.84%
Company Profile
- Volume Average 10.47K
- Market Capitalization 714.87M
- Employee 91
- CEO Mr. Richard Paxman O.B.E.
- Headquarters Karlshamn,SE
- IPO Date 2017-06-12
-
Website
https://paxmanscalpcooling.com 
Paxman AB (publ), together with its subsidiaries, develops and sells Paxman scalp cooling system to minimize hair loss in connection with chemotherapy treatment in Europe, the United States, Mexico, Japan, Oceania, rest of Asia, and South and Central America. It serves various cancer centers and hospitals. The comapny has a research collaboration agreement with National University Hospital, Singapore for the development of portable cooling and compression device. Paxman AB (publ) was founded in 1996 and is based in Karlshamn, Sweden.
